Acute Lymphocytic Leukemia

What is acute lymphocytic leukemia?

Acute lymphocytic leukemia (often shortened to ALL, and also called acute lymphoblastic leukemia) is a cancer of the blood and bone marrow. Bone marrow is the soft, spongy tissue inside bones where blood cells are made. In acute lymphocytic leukemia, the marrow produces large numbers of immature white blood cells called lymphoblasts. These abnormal cells do not work properly and do not mature into healthy lymphocytes, the white blood cells that normally help the body fight infection.

The word acute means the disease tends to develop quickly, usually over days or weeks, and generally needs treatment soon after it is found. This is different from chronic leukemias, which progress more slowly. As the lymphoblasts multiply, they crowd out normal red blood cells, platelets (cells that help blood clot), and healthy white blood cells. Many of the symptoms come from this shortage of normal cells.

Acute lymphocytic leukemia is the most common type of cancer in children, and it is most frequently diagnosed in early childhood. It can also occur in teenagers and adults, and a second, smaller peak in new cases is seen in older adults. Doctors divide ALL into subtypes based on which kind of lymphocyte is affected. B-cell ALL starts in early forms of B lymphocytes and is the most common subtype. T-cell ALL starts in early forms of T lymphocytes and is somewhat more common in teenagers and young adults. The subtype, along with specific genetic changes in the leukemia cells, helps guide treatment decisions.

Acute lymphocytic leukemia symptoms

Acute lymphocytic leukemia symptoms are often vague at first and can resemble those of common infections such as the flu. Because the disease develops quickly, symptoms usually appear and worsen over a few weeks rather than months. Many people first notice unusual tiredness or frequent infections.

Common symptoms include:

• Persistent tiredness or weakness
• Pale skin
• Fever, often without an obvious infection
• Frequent or repeated infections
• Easy bruising or bleeding, including nosebleeds or bleeding gums
• Small red or purple spots on the skin (petechiae) caused by bleeding under the skin
• Bone or joint pain
• Swollen lymph nodes in the neck, underarms, or groin
• Swelling or a feeling of fullness in the abdomen from an enlarged spleen or liver
• Shortness of breath
• Unexplained weight loss or loss of appetite
• Night sweats

These symptoms follow from what the leukemia does inside the marrow. Too few red blood cells (anemia) causes tiredness, pallor, and breathlessness. Too few normal white blood cells leaves the body less able to fight infection, which explains fevers and repeated illnesses. Too few platelets leads to easy bruising and bleeding.

Symptoms can differ somewhat by subtype. T-cell ALL is more likely to involve the thymus, a small gland behind the breastbone. When the thymus becomes enlarged, it can press on the windpipe or nearby blood vessels, causing cough, breathing difficulty, or swelling of the face and arms. In a smaller number of people, leukemia cells spread to the fluid around the brain and spinal cord. This can cause headaches, vomiting, blurred vision, or weakness, and it is one reason treatment routinely includes steps to protect the central nervous system. Leukemia cells may also collect in the testicles in boys and men, causing painless swelling.

None of these symptoms is specific to leukemia, and most people who have them will turn out to have something less serious. However, symptoms that persist or occur together warrant medical assessment.

Causes and risk factors

The exact acute lymphocytic leukemia causes are not fully understood. What is known is that the disease begins when a developing lymphocyte in the bone marrow acquires changes (mutations) in its DNA. These changes cause the cell to keep dividing and to stop maturing, and the abnormal cells gradually take over the marrow. In most people, these mutations are acquired during life rather than inherited, and in the majority of cases no clear reason for them can be identified.

Researchers have identified several factors that appear to raise the chance of developing ALL, although having a risk factor does not mean a person will get the disease, and many people with ALL have no known risk factor at all:

• Age: risk is highest in young children and rises again in older adults.
• Previous cancer treatment: certain chemotherapy drugs and radiation therapy given for other cancers can, in some people, lead to leukemia years later.
• High-dose radiation exposure: for example, survivors of nuclear accidents have shown increased rates of leukemia.
• Genetic conditions: some inherited disorders, including Down syndrome, are associated with a higher risk of ALL.
• Family history: having a sibling, particularly an identical twin, with ALL slightly increases risk, although most cases are not familial.
• Certain chemical exposures: long-term exposure to chemicals such as benzene has been linked to leukemia, though the association is clearer for other leukemia types.

Acute lymphocytic leukemia is not contagious. It cannot be passed from one person to another, and it is not caused by anything a parent did or did not do during pregnancy or childhood. Research into possible links with infections in early life and immune system development is ongoing, but no single environmental trigger has been confirmed.

Acute lymphocytic leukemia diagnosis

Acute lymphocytic leukemia diagnosis usually begins when a blood test shows abnormal results. A doctor may order a complete blood count, a test that measures the numbers of red cells, white cells, and platelets. In ALL, the white cell count may be very high or, in some cases, low, while red cells and platelets are often reduced. A peripheral blood smear, in which a drop of blood is examined under a microscope, may show lymphoblasts that should not normally be present in the bloodstream.

To confirm the diagnosis, doctors perform a bone marrow aspiration and biopsy. Using a needle, a small sample of liquid marrow and a tiny core of bone are removed, usually from the back of the hip bone, under local anesthesia. A specialist called a hematopathologist examines the marrow for lymphoblasts. ALL is generally confirmed when a defined proportion of the marrow cells are lymphoblasts; in most classification systems, the threshold is about 20 percent or more.

Several laboratory tests are then run on the leukemia cells to characterize them precisely:

• Flow cytometry (immunophenotyping): identifies proteins on the surface of the cells and determines whether the leukemia is B-cell or T-cell type.
• Cytogenetic analysis: examines the chromosomes in the leukemia cells for changes such as missing, extra, or rearranged pieces.
• Molecular and genetic testing: looks for specific gene changes, such as the Philadelphia chromosome (a fusion of parts of chromosomes 9 and 22), that influence treatment choice and expected response.

Because ALL can spread to the fluid around the brain and spinal cord, a lumbar puncture (spinal tap) is usually performed. A thin needle is inserted into the lower back to collect a small amount of cerebrospinal fluid, which is then checked for leukemia cells. Imaging tests such as a chest X-ray, CT scan, or ultrasound may be used to look for an enlarged thymus, swollen lymph nodes, or enlargement of the spleen or liver. Additional blood tests check kidney and liver function, blood clotting, and levels of substances released by rapidly dividing cells.

Unlike many solid tumors, ALL is not staged by size or spread. Instead, doctors classify it by subtype, genetic features, the person’s age, the initial white blood cell count, and whether the central nervous system is involved. These features are grouped into risk categories that help determine how intensive treatment should be. In hospital groups such as Acibadem, this evaluation is typically coordinated by hematology and oncology specialists working with laboratory and imaging teams.

Acute lymphocytic leukemia treatment options

Acute lymphocytic leukemia treatment options depend on the subtype, genetic findings, age, general health, and how the disease responds to initial therapy. Because ALL progresses quickly, treatment usually begins soon after diagnosis. Observation without treatment is not an approach used for acute leukemia. Surgery also plays no role in removing the disease, because leukemia cells circulate throughout the blood and marrow rather than forming a single tumor.

Chemotherapy is the main treatment. Chemotherapy uses medicines that kill rapidly dividing cells or stop them from multiplying. It is typically given in phases over a long period, often about two to three years in total:

• Induction: the first, most intensive phase, usually lasting several weeks and often requiring time in hospital. The goal is to destroy as many leukemia cells as possible and restore normal blood production, a state called remission.
• Consolidation (intensification): further courses of chemotherapy given after remission to eliminate leukemia cells that may remain but cannot be seen under the microscope.
• Maintenance: lower-dose treatment, often taken largely at home as tablets with periodic injections, continued for a long period to reduce the chance of the leukemia returning.

Central nervous system therapy is included in almost every plan. Chemotherapy is injected directly into the spinal fluid during lumbar punctures (intrathecal chemotherapy) because many drugs given by vein do not reach the brain and spinal cord well. In some situations, radiation to the head may also be used.

Targeted therapy refers to medicines that act on specific abnormalities in leukemia cells. For example, people whose leukemia carries the Philadelphia chromosome are usually given tyrosine kinase inhibitors, drugs that block the abnormal protein produced by that genetic change, alongside chemotherapy.

Immunotherapy uses the immune system to attack leukemia cells. Antibody-based drugs that bind to proteins on B-cell leukemia cells may be used in certain situations, particularly when the disease has not responded fully or has come back. CAR T-cell therapy is a treatment in which a person’s own T cells are collected, modified in a laboratory to recognize leukemia cells, and returned to the body. It is currently used for selected people with B-cell ALL that has relapsed or resisted other treatments.

Stem cell transplantation (also called bone marrow transplantation) may be recommended for people at higher risk of relapse or whose disease has returned. It involves very high-dose chemotherapy, sometimes with radiation, followed by infusion of healthy blood-forming stem cells, most often from a donor. This is an intensive procedure with significant risks, and it is not needed for everyone with ALL.

Supportive care is a vital part of treatment. This includes transfusions of red blood cells or platelets, antibiotics and antifungal medicines to prevent or treat infection, medicines to control nausea, and careful monitoring of kidney function during the early phase when many leukemia cells break down at once. Nutrition support, physical therapy, and psychological support help people cope with the physical and emotional demands of a long treatment course. Rehabilitation may be helpful after prolonged hospital stays to rebuild strength and stamina.

Clinical trials are an important part of how ALL treatment continues to improve, and your doctor may discuss whether a trial is appropriate. The Medical Oncology Department is among the units that manage this condition in adults, typically alongside hematology and, where relevant, transplant teams.

Living with acute lymphocytic leukemia and outlook

The outlook for acute lymphocytic leukemia varies widely and depends on many factors, including age at diagnosis, subtype, genetic features of the leukemia cells, and how quickly the disease responds to treatment. In general, children have a more favorable outlook than adults, and many children treated for ALL go on to live long, healthy lives. Outcomes for adults have improved over time as treatment has become more refined, though ALL in adults remains more challenging to treat, particularly in older people.

Doctors often measure early response by testing for minimal residual disease, which means very small numbers of leukemia cells detected by sensitive laboratory methods after treatment. A negative result is generally associated with a better outlook, while a positive result may lead to more intensive treatment. Relapse, when the disease returns after remission, is possible and is one reason follow-up continues for years after treatment ends.

Living through ALL treatment is demanding. Fatigue, hair loss, mouth sores, nausea, and increased infection risk are common during intensive phases. Long-term or late effects can occur months or years after treatment and may include effects on the heart, bones, fertility, growth in children, and learning or concentration. For this reason, survivors usually receive ongoing follow-up, and many centers offer survivorship programs that monitor for late effects. Emotional support for patients and families, whether through counseling, support groups, or social work services, is considered an important part of care. No one can guarantee a particular outcome, but treatment for ALL has a well-established track record, and your care team can explain what the findings in your specific case are likely to mean.

Frequently asked questions

What is acute lymphocytic leukemia in simple terms?

Acute lymphocytic leukemia is a fast-growing cancer that begins in the bone marrow, where blood cells are made. The marrow produces too many immature white blood cells called lymphoblasts, which crowd out healthy blood cells. This leads to tiredness, infections, and bleeding problems. It is the most common childhood cancer but can affect adults as well.

What are the first acute lymphocytic leukemia symptoms?

Early symptoms are often nonspecific and may include persistent tiredness, pale skin, fever, frequent infections, easy bruising, and bone or joint pain. Because these can be caused by many common illnesses, ALL is frequently found when a blood test done for another reason shows abnormal results. Symptoms tend to worsen over weeks rather than months.

What causes acute lymphocytic leukemia?

In most cases, the cause is not known. ALL develops when DNA changes occur in developing lymphocytes, causing them to multiply uncontrollably. Known risk factors include previous chemotherapy or radiation, high-dose radiation exposure, and certain genetic conditions such as Down syndrome. It is not contagious and is not caused by lifestyle choices or parenting.

How is acute lymphocytic leukemia diagnosis confirmed?

Diagnosis begins with blood tests, but confirmation requires a bone marrow aspiration and biopsy, in which a sample of marrow is examined for lymphoblasts. Additional tests such as flow cytometry and genetic analysis identify the subtype and specific changes in the leukemia cells. A lumbar puncture is usually done to check whether the disease has reached the fluid around the brain and spinal cord.

What are the main acute lymphocytic leukemia treatment options?

Chemotherapy given in phases over about two to three years is the foundation of treatment. Depending on the subtype and response, this may be combined with targeted drugs, immunotherapy, or CAR T-cell therapy. Stem cell transplantation may be recommended for people at high risk of relapse. Treatment always includes measures to protect the central nervous system and supportive care to manage side effects and infections.

Can acute lymphocytic leukemia be cured?

Many people, particularly children, achieve long-term remission after treatment, and doctors may describe this as a cure when the disease has not returned after several years. Outcomes in adults are generally less favorable but have improved. Individual prognosis depends on age, subtype, genetic features, and early response, so it is best discussed with the treating team.

Is acute lymphocytic leukemia hereditary?

ALL is usually not inherited. The genetic changes that drive it are almost always acquired during a person’s life rather than passed down from parents. A small number of inherited conditions increase risk, and siblings of a child with ALL have a slightly higher chance, but the vast majority of relatives of people with ALL never develop the disease.

When to see a doctor

Many symptoms of acute lymphocytic leukemia overlap with common, less serious illnesses. Still, it is sensible to have a medical evaluation if you or your child has tiredness, pallor, bruising, or bone pain that does not go away, or repeated infections without a clear explanation. A simple blood test can often rule leukemia in or out.

Seek urgent medical care if any of the following occur, whether before a diagnosis or during treatment, when the immune system is weakened:

• Fever, especially with chills, in someone receiving chemotherapy or known to have low white blood cells
• Bleeding that will not stop, blood in urine or stool, or vomiting blood
• Widespread bruising or a sudden rash of small red or purple spots
• Severe headache, repeated vomiting, confusion, or new weakness or vision changes
• Difficulty breathing, chest pain, or swelling of the face and neck
• Extreme paleness with dizziness, fainting, or a racing heartbeat
• Severe or worsening bone pain, particularly in a child who refuses to walk

These signs may indicate serious complications such as infection, bleeding, or pressure on vital structures, all of which need prompt assessment.